MacroGenics reported $9.5M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
AbbVie USD 5.31B 178M Sep/2026
Amgen USD 6.39B 169M Sep/2026
AstraZeneca USD 6.93B 362M Jun/2026
Biogen USD 2.22B 159.9M Sep/2026
Bristol-Myers Squibb USD 2.7B 33M Sep/2026
Daiichi Sankyo JPY 733.05B 40.68B Jun/2026
Eli Lilly USD 18.19B 1.4B Sep/2026
Genmab DKK 21M 8M Mar/2026
Geron USD 126.6M 3M Sep/2026
Gilead Sciences USD 1.9B 57M Sep/2026
J&J USD 15.38B 233M Sep/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 9.5M 1.59M Mar/2026
Merck USD 6.16B 43M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025